YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

about

Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma A feed forward loop enforces YAP/TAZ signaling during tumorigenesis Repurposing of Drugs Targeting YAP-TEAD Functions

P2860

Q57646291-4655D258-A638-48DE-9933-8B7DE853F0DC Q58695672-738B4866-FD8B-4A84-9B47-3BBDF55AF184 Q58739088-A608CEE6-6279-4256-B544-5263EA2CAFA7

P2860

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

Item

http://www.wikidata.org/entity/Q54977387

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

@en

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

@nl

type

Item

label

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

@en

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

@nl

prefLabel

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

@en

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

@nl

P1476

YAP/TAZ Activation as a Target for Treating Metastatic Cancer

@en

P2093

John M Lamar

http://www.w3.org/2001/XMLSchema#string

P2860

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP

Integrin-regulated FAK-Src signaling in normal and cancer cells

Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation

Tumor suppressor LATS1 is a negative regulator of oncogene YAP

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis

Role of TAZ as mediator of Wnt signaling

P31

scholarly article

P356

10.3390/CANCERS10040115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yuxuan Xiao

Janine S A Warren

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29642615

http://www.w3.org/2001/XMLSchema#string

P932

5923370

http://www.w3.org/2001/XMLSchema#string

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

about

P2860

P2860

YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932